BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33113454)

  • 1. Oropharyngeal carcinoma: A single institution study of 338 primaries with special reference to high-risk human papillomavirus-mediated carcinoma with aggressive behavior.
    Alexiev BA; Obeidin F; Johnson DN; Finkelman BS; Prince R; Somani SN; Cheng E; Samant S
    Pathol Res Pract; 2020 Dec; 216(12):153243. PubMed ID: 33113454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell anaplasia and multinucleation are predictors of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the human papillomavirus-related cancers.
    Lewis JS; Scantlebury JB; Luo J; Thorstad WL
    Am J Surg Pathol; 2012 Jul; 36(7):1036-46. PubMed ID: 22743286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
    Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
    Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
    Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
    Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 expression in cutaneous squamous carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck.
    Beadle BM; William WN; McLemore MS; Sturgis EM; Williams MD
    Head Neck; 2013 Nov; 35(11):1527-33. PubMed ID: 23108906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis.
    Carpenter DH; El-Mofty SK; Lewis JS
    Mod Pathol; 2011 Oct; 24(10):1306-12. PubMed ID: 21572403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
    Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
    J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
    Rischin D; Young RJ; Fisher R; Fox SB; Le QT; Peters LJ; Solomon B; Choi J; O'Sullivan B; Kenny LM; McArthur GA
    J Clin Oncol; 2010 Sep; 28(27):4142-8. PubMed ID: 20697079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.
    Lewis JS; Thorstad WL; Chernock RD; Haughey BH; Yip JH; Zhang Q; El-Mofty SK
    Am J Surg Pathol; 2010 Aug; 34(8):1088-96. PubMed ID: 20588174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma.
    Lewis JS; Ali S; Luo J; Thorstad WL; Madabhushi A
    Am J Surg Pathol; 2014 Jan; 38(1):128-37. PubMed ID: 24145650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oropharyngeal Squamous Cell Carcinoma With Discordant p16 and HPV mRNA Results: Incidence and Characterization in a Large, Contemporary United States Cohort.
    Shinn JR; Davis SJ; Lang-Kuhs KA; Rohde S; Wang X; Liu P; Dupont WD; Plummer D; Thorstad WL; Chernock RD; Mehrad M; Lewis JS
    Am J Surg Pathol; 2021 Jul; 45(7):951-961. PubMed ID: 33739785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful?
    Schulte JJ; Steinmetz J; Furtado LV; Husain AN; Lingen MW; Cipriani NA
    Head Neck Pathol; 2020 Dec; 14(4):966-973. PubMed ID: 32350806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
    Kraft S; Faquin WC; Krane JF
    Am J Surg Pathol; 2012 Mar; 36(3):321-30. PubMed ID: 22301491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16 expression in follicular dendritic cell sarcoma: a potential mimicker of human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Zhang L; Yang C; Lewis JS; El-Mofty SK; Chernock RD
    Hum Pathol; 2017 Aug; 66():40-47. PubMed ID: 28554574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.